Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             22 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy Henricks, Linda M.
2019
107 C p. 60-67
artikel
2 An open-label, multicentre safety study of vemurafenib in patients with BRAF V600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system Larkin, James
2019
107 C p. 175-185
artikel
3 A novel risk calculator to predict outcome after surgery for symptomatic spinal metastases; use of a large prospective patient database to personalise surgical management Choi, David
2019
107 C p. 28-36
artikel
4 Association of quality of life with disease characteristics and treatment outcomes in patients with advanced gastric cancer: Exploratory analysis of RAINBOW and REGARD phase III trials Chau, Ian
2019
107 C p. 115-123
artikel
5 Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program Buron, Andrea
2019
107 C p. 53-59
artikel
6 Common genetic variants contribute to incomplete penetrance: evidence from cancer-free BRCA1 mutation carriers Downs, Bradley
2019
107 C p. 68-78
artikel
7 Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning Suchorska, Bogdana
2019
107 C p. 15-27
artikel
8 Delayed immune-related adverse events in assessment for dose-limiting toxicity in early phase immunotherapy trials Kanjanapan, Y.
2019
107 C p. 1-7
artikel
9 Development of mild drug-induced sclerosing cholangitis after discontinuation of nivolumab Noda-Narita, Shoko
2019
107 C p. 93-96
artikel
10 Dramatic response of nivolumab-associated psoriasiform dermatitis to etoposide Rios, Adan
2019
107 C p. 97-99
artikel
11 Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy Zandberg, Dan P.
2019
107 C p. 142-152
artikel
12 Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core Liegl, G.
2019
107 C p. 133-141
artikel
13 General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States Nolte, S.
2019
107 C p. 153-163
artikel
14 Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors Hasan Ali, Omar
2019
107 C p. 8-14
artikel
15 Long-term survival in patients with advanced non–small-cell lung cancer treated with atezolizumab versus docetaxel: Results from the randomised phase III OAK study von Pawel, J.
2019
107 C p. 124-132
artikel
16 Oxaliplatin, 5-Fluorouracil and Nab-paclitaxel as perioperative regimen in patients with resectable gastric adenocarcinoma: A GERCOR phase II study (FOXAGAST) Watson, S.
2019
107 C p. 46-52
artikel
17 Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre Ruatta, F.
2019
107 C p. 79-85
artikel
18 Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer Hakenberg, Oliver W.
2019
107 C p. 186-195
artikel
19 Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase Schwartz, Sarit
2019
107 C p. 164-174
artikel
20 Role of CCL5 and CCR5 gene polymorphisms in epidermal growth factor receptor signalling blockade in metastatic colorectal cancer: analysis of the FIRE-3 trial Suenaga, Mitsukuni
2019
107 C p. 100-114
artikel
21 SWITCH II: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of advanced or metastatic renal cell carcinoma (AUO AN 33/11) Retz, Margitta
2019
107 C p. 37-45
artikel
22 Topographical distribution of sentinel nodes and metastases from T1–T2 oral squamous cell carcinomas Mølstrøm, Jacob
2019
107 C p. 86-92
artikel
                             22 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland